A bst ract lntravascular papillary endotheiial hyperplasia is a benign lesion ofvascular origin that is caused by an excessive proliferation of endothelial eelis in normal blood vesseis or vascular malformations. We report the case of a 26-year-old man who had such a lesion deep within the sof t tissues of his neck. Imaging studies revealed a 6-cm-diam eter mas s, with its epice nte r in the right retromandibular space. The mass extended into the right parapharyngeal spac e and compressed the pharynx. The mass was excised, and the pati ent recovered uneventfully. We discuss the mana gement ofthis lesion, with emphasis on radiologic and histologic assessment and the differ ential diagnosis .
Introduction
Unexplained swelIing in the head and neck region poses a diagnostic dilemma for clinicia ns. One such difficu lt-todiagnose entity is intravascular papillary endotheIial hyperpla sia (IPEH) , also known as intravascular angiomatosis , Masson 's pseudoan giosarc oma , and vegetant intravascular hemangioendothelioma . IPEH is a benign lesion of vascular origin that is caused by an excessive proliferation of endotheIial eelIs in normal blood vesseIs or vascular malformations.
Although it is ubiquitous in nature, I IPEH has a predilection for the head and neck region .v' Most of the reported head and neck cases have involved only the skin and the subcutaneous tissue s of the face and scalp.t? Less common sites include the buccal mucosa; " tongue.?:'? pharynx, II masseter muscle ,12 and parotid gland.' IPEH of the maxillary sinus, " mandible," orbit ," and ocular adnexa" has also been observed. Only five IPEH patient s have been reported to have an anterior neck mass; one was in the external jugular vein," one in the vasculature beneath the platysma muscle, " and three in organizing hem atomas of the thyroid gland . 19 • 20 One case of IPEH in the superior vena cava that caused obstructive symptoms has also been reported."
In this article, we report the case of a patient who had an IPEH deep within the soft tissues of the neck, which manifested as a lateral neck mass. We also describe its radiologic appearance on computed tomography (C'I') and magnetic resonance imaging (MRI). In most previously reported cases, radio logic investigations either were not performed or their significance was not noted . The purpo se of this report is to alert clinic ians to the potential for misdiagnosing IPEH at the clinical , radiologic, and histologic levels, particularly those who are unfam iliar with this lesion .
Case report
A 26-year-old man came to the hospital2 days after he had developed a painful swelIing on the right side ofhis neck. He had no history of trauma or reeent dental or oropharyngeal infection, and his medical history was unremarkable. On clinical examination, his oral temperature was 100°F (37.8°C) and his pulse rate was 90 beats per minute . General and systemic examinations were norma!.
On his neck, a tender, noncystic, nonpulsatile mass meas uring 5 x 4 cm extended from the angle of the right ENT :~~~?J:~i l i e~Ĩ~~a~:~~\ I _~~: p; ;d~~~no l°o~vf~r s~~I~; ĩ~s'~~~~~~~~ms~~~: ; -; : \~:~a: er :~~~~~g events voluntarily Irom a populalion01 unknov," SilO,eslimatesof lrequencycannol be made. Theevenlshave been ch osenforinclusionduetoacombinati on oftheir seriousness, frequencyofreporting, orpotential causal eonneelion 10 l OFRA N. General: Rushing. Rarecases of hype" ensilivity reaclions, somelimessev ere (e.g., anaphylaxislanaphylaeloid reacti ons,angioedema, bronehospasm,shortness of brealh, hypotension, laryngeal edema, stridor)have also been reported. l aryngospasm, shoek, and eardiopulmonary arresl haveoeeurred during allergie reaclion s in patients reeeiving Injectable ondansetron.
r:~~~~~~~r ,~~; !~ĩ~~~abnormalilies
NeuroIogr : Oeulogyrie crisis, appearing al ane, aslVell aswilh olherdyslonie reacl ions Skin: Urtiearia ORUGASUSEANDOEPENOENCE: Animal sludieshave shown Ihal ondanselronis noI diserim inal edasa benzodiazepine nor doesit substituteforben zodiazepines indireetaddiction studies. OVERO OSAGE: There is no speeifie anlidolelor ondanselron overdose. Palienls should bemanagedwilh approprialesupportiveIherapy. Individual doses aslargeas150 mg and tolal daily doses aslarge as252mg havebeeninadvertentJy administered intravenously wit houtsigniflcant adverse events. Thesedoses aremore than 10 times Ihe reeommended daily dose.
In addition 10 Ihe adverse evenls IlSledabove, Ihe following evenls have been deseribedin thesetting 01 ondansetron overdose: "Sudden blindness" (amaurasis)of2 to3 minutesduration pius severeconstipation occurred in one patien t that was administe red 72 mg o( ondansetronint ravenously asasi ngle dose. Hypolension (and laintness) oeeurredin a palienlIhallook 48 mg of lOFRANTablels. Followinginlusion 01 32 mg over only a 4-minule peri od,a vasovagal episode with lransienl second degreeheartblock was observed. In all inslanees, Ihe even ls resolved eomplelely.
BRIEFSUMMARY
Thefoll O W ing adverseevents have been reportedIn~5% 01 adultpalient s reeeiving eoneurrent moderalely emetogenie ehe mol herapy, primarily cyelophosphamide-based regi mens.
T ab l~5~; r~~C~~I NA~:~I~I ;~~~J :~W~~~Ĩ~~~I~~~~~01~:~: ) With Cen/ral Nervous Sysl em : Therehavebeen rarereportseonsislenl wtth , but noi diagnostieof,extrapyramidal reaetions in patientsreceivingondan setron.
Hepali e: In 723palienl s reeeivi ngcyelophos phami de-based ehemolher apy in USelinical lrial s,ASTandlor ALT values havebeenreportedtoexc eed twicetheupperlimitof normalinapproximately 1%to2%ofpaUentsreceiving ZDFRAN Tablels. The inereases lVerelransienl and didnoiappear 10 berelaled to dose or duration of Iherapy. On repeat exposure, similar transient elevations intransaminasevaluesoecurred insomecourses, but symptomatie hepalie dlSease didnoI oeeur. The role ofcaneer ehemotherapyin these bioehemical ehanges eannol beelearly determined.
Therehave beenreports01liver fail ure and deathinpalients witheancer reeeivi ngconeurrent medi cations ineluding polenlially hepaloloxie cytoloxie ehemolherapy and anl ibiolies. Theeliology ofIheliverlailureIs unelear.
Integumentary: Rashhasoecu rred inapproximately 1%of patients receiving ondansetron. Dlher: Rare cases 01anaphylaxis, bronehospasm, taehycardia, angina(cheslpain), hypokalemia, eleelrocardiographiealleral ions,vaseularoeelusi ve evenl s,andgrand maf seil ures havebeen reported. Exeepl lor bronehospasm and anaphylaxis, therelalionship10 lOFRANwas unelear. Radiatlon·lnduced Nausea and Vom iling: Theadve"eeventsreported in pali enls receivinglOFRAN Tablets and eoneurrent radiotherapy weresimilar10Ihosereported in patienls reeeivinglOFRAN Tablels and eoneu rrenl ehemotherapy. Themosllrequenttyreportedadve"eevenlswereheadaehe, eonslipalion,and diarrhea . Posloperalive Nausea andVo miting: The lollowing adve" e events havebee n reported in~5% 01 adul l pal ienls reeeivlng multiple eoneomttanl per ioperative and posloperal ivemedications. Wilhtheexeep tionof headaehe, rates 01 these events were noi signilicanllydifferent intheondansetron andplaceba groups. Cardiovascular: Arrhythmias (includi ng ventricular andsupraventricular tachy cardia. premature ventricular contracnons, and atrial fibrillal ion), bradycardia, eleet rocar diographieatteratlons(ineluding second degreeheart block), palpilalions, and syncope.
General: Flushing. Rarecases 01 hype" ensi tivity react ions, somelimes severe (e.g., anaphyl axisl anaphylaeloid reaetions, angioedema, bronchospasm, cardiopulmonary arrest, hypot ension, laryngeal edema, laryngospasrn, shock, shortness of breath,slridor) ha vealso been reported, Hepalobiliary:l iverenzymeabnormali lieshave been reported. l iverlai lureand dealh havebee n reportedin patents wilhcancer receiving coneu rrem medlcations includinp polenlially hepatotcxlc cytol oxie ehe molherapy and anlibiolies. Theetiology 01 Iheiiverfailure is unelear.
Loeal Reael/ons: Pain, redness, and burningal sile01inj eelion. LowerRespfralory: Hie eups NeuTologleal: Oeulogyri e cri si s,appearing alane, asweil aswilh olherdystonl c reaclions. Skin: Urti caria Speci al Sen ses : Transient blurredvision, insome casesass ociated withabnormali ties ofaccommodation, and transentdizzinessduring or shortlyatter I.V . infusion. lOFRANTASlETS: AOVERSE REACTIONS: Thelollowingha vebeen reported asadverse events in eli nicallrials 01 patients treated wilhondansetron, Acausal relatio nship10Iherapy wtt h lOFRAN hasbeen unel ea r in many cases. Chemolherapy-Induced Nausea and Vom iling: Thelollowing adverse events havebeen reported in~5 % of adult patients reeelV ingeoneur rent highly emelogenie cisptatin-based ehemotherapy regimens (eisplalin dose~50 mglm'). Gas/roin/estinal : Conslipalion has been reported in 11% of ehemolherapypat ienl s receivingmulliday ondanselr on. Hepatic: Ineomparalivetrial s in eisplalin ehemolherapy pal ients withnormal baselinevalues 01 aspartale lransaminase (AST) and al anine transaminase (ALn, these enzymes have been reported to exceed twICe theupper Iimitofnormal inapproximately 5% of patients. The increases we retransient and did not appear to be relatedto dose orduration oftherapy. On repeat exposure, si milar transient elevatlons intransaminase values oee urred in some cou rses, but symptomatiehepatie disease did notoeeur.
Int egumentary: Rash hasoecurred inapproximatel y 1% ofpatients reeeiving ondansetron. Neurologi eal : Therehave been rarereports eonsislent wilh, bulnoi diagnosti eof, extrapyramidalreaclions in palienl s reeeiving lOFRAN Injeelion, and rare cases of grand maise~ure . Therelalionship10 ZDFRAN was unelear.
Dlher: Rare cases 01 hypokal emiahavebeen reported. Therelal ionship 10 ZDFRAN Injeelion\'lasunelear. Posloperalive Nausea andVom lting(PONV):The following adve"e evenlsha vebeen reportedinpali enls reeeiving mulliple eoneomilanlperioperaliveandposloperativemedicalions. Ralesof theseevenls were not signifieantly di"eren l inIheondanselron and plaeebo groups. 
IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING (PONV)
Call the Cilaxo Wellcome Customer Response Center at 1-888-825-5249 for more information.
ZOFRAN is a proven antiemetietherapythat has been tried and trusted for mare than 6 years. Millions of healtheare professionals have relied on ZOFRAN for their patients-and you can too. The most commonly reported adverseevents in patients reeeiving ZOFRAN in c1inical trials were headaehe (5% to 27%), diarrhea «1% to 16%), eonstipation «1% to 9%), fever «1% to 8%), and malaise/fatigue (0% to 13%).'
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INTRAVASCULAR PAPILLARY ENDOTHELl AL HYPERPLASIA (MASSON'S TUMOR) MA NIFESTING AS A LATERAL NECK MASS ma nd ible into the parapharyngeal space. Th e mass appeared to be fixed to deeper tiss ues . Th e overly ing ski n was norm al , and there we re no palp abl e cervical na des. There was no bru it, trismus, or intraoraI sign o f infection . Th e mass protruded into the pha rynx and pu shed the right to nsil and soft palate mediall y. T he nose, nasopharynx, hyp oph aryn x, laryn x, and ears were normaI an exami nation , and the cranial nerves we re not invo lve d. Co mple te blood co unt, se rum elec tro lyte, and renal fun ction measureme nts were norm al, as was the ches t x-ray. Th e pati ent tested HIV -negative. After 3 day s of treatment wi th a broad-spect rum antibiotic, ind ometh acin, and an antiseptic mouthwash , the patient' s pain and temp eratu re subsi de d, but the swe lling per sisted . CT was orde red, and it revealed a 6-c m-dia me te r mass . It s e picenter was lo cat ed in th e ri gh t retrom andibular space . Th e mass extended into the rig ht parapharyn geal space and co mpressed the ph aryn x. Th e lesion was c1early se pa rate fro m the parotid gland. Th e mass was of low density on precontrast CT , and it displayed a pe ripheral enhance me nt on postcontrast seannin g. Calcification was notably abse nt.
MRI co nfirmed that a well-defined nonhom ogen ou s mass had abutted and ero de d the med ial side of the right mand ibular ramus (figure I). Th e mass exhibited a patch y ce ntra l enha nce me nt afte r the administration of gadolinium. Fin e-needl e aspiratio n o n two a ccasions was not help ful becau se the as pirate con sisted enti rely of blood . At surge ry , a pa arl y encapsulated vascular ma ss was enco untered in the region of the righ t tail of the parot id gla nd. Th e mass ex tended up toward the pterygoid plates and mu scles. Th e surgeon ligated all sma ll feedi ng vesseIs and excise d the mass in its entirety.
Micro scop ic examination disclosed the presen ce of a my riad of papillary struc tures that we re characteri ze d by central coll agen ized cores , which were surrounded by an att enu ated si ng le layer of en do the lium (figure 2). Dilated vesseIs, focal hernorrh age with hem osid erin deposition , and organ izi ng throm bi were noted. Th e surrounding stro ma featured a mono nuclear intl ammatory ce ll infiltra te . T here was no cy tologic atypi a of necrosis. Exam ination of the adj ace nt parotid gland rev ealed a chronic sialade nitis with inters titial fibrosis. Postoperativel y, the patien t was left with a mild righ t mandibul ar facia l palsy.
On e year later, he was weil wit ho ut any evide nce of recurren ce. 
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Discussion
Cl inically , IPEH usu all y man ifests as a fir m and so metimes tend er mass th at imparts a reddi sh-blue col or to the overlying skin or mucous memb rane. T he age distr ibuti on is wid e (9 mo-80 yr),22 and most series report a sIightly higher incidenee among fernales.v"
Because its elinical signs and symptoms are non specific, IPEH , !ike most other vascular malfo rma tio ns, poses a difficult di agnostic challen ge." T his is partic ularl y true with the deeper intra muscu lar lesion s." In our case, the patient ' s pain mig ht have been ca used by the compression of the parotid gIand and other adjacent struc tures. nonh om ogen ou s as we il as contrast-enh ancin g.P-' ? Su ch signals are prob abl y related to the fact that lesions are likely to hav e varying amo unts of both so!id " pare nchy rnal" tis sue are as (papillary structures and thro mbi ) and anas tomo tic, stag nant, or low-flow vascular cha nnels.
Areas of microcalci fication have been not ed in IPEH lesions.v -" Phleboliths, however , are also common in pati ent s with hem angi om as. Like wise , calcificati on ca n occur in hem atom as and tum ors, and they can foll ow necrosis of soft tissues. Moreover , on angiog raphy, IP EH ca n mani fest as eithe r a vascular or avascular mass." MRI is usuall y superior as the initial diagn ostic test fo rvascular ma lformati ons, and furth er inves tigatio ns are usua lly not necessary in low-flow lesions." Th e CT , M RI, and an giographi c patterns of IPEH ca n all simulate other benign (e.g., heman giorna" ) and mal ign ant (e.g., angiosarco ma" ) co nd itions . of pressure effe ets, its radiolog ie features ean be even mare sugges tive of malignanc y.I-" Th erefore , while radiologie inves tiga tions ea n eontribute to man agement, they are not suffi eiently eharaeteristie by them selves to make a diagnosis of IPEH. Th e diagno sis is best established with a histologie exam ination-al' eytolo gieally if the aspirate co ntains suffie ient eelis in addition to blood and fibrinoid material-" -" Histologic evaluation. Micro scopic ally, IPEH is a welleireums eribed lesian made up of stro mal papill ae that are lined with end oth eIial eelis. Th ese papill ary struetures ean fuse to form an anastom a sing vaseular netw ork, such as that assoc iated wit h thrombosis. Infl amm ato ry eelis are usually few in number. In rare instanees, a rupture of the vessel of ori gin permits the spilling over of proliferatin g endotheIial eelis into surrounding soft tissue , a phenomenon that should not be equated with malignancy."
Pathogenesis. Th ere are three types ofIPEH: (I ) a pur e (pr im ary) form that arises de novo in dilated vase ular spaees, (2) a mixed (seeondary al' reaetiv e) form that oeeurs foeally in pre-existin g variees, hemangiom as, and arteriovenous malformations, and (3) a rare ex trav ase ular form that arises in hem atornas." The pathogen esis of IPEH remains spee ulative. Masson , in 1923 , regarded this eondition as a true neopl asm with seeondary thrombo-SiS. 39 Howe ver, its form of presentation , its assoc iation wi th other lesions, and its pattern of growth are mare suggestive of a beni gn reaetive proce ss, perhaps related to traurn a.t?"' Ou r patient had no such sig nifiea nt histo ry.
The frequeney with wh ieh thrombi are found in these lesion s have led so me auth ors to propose that IPEH represent s an unu sual form of thrombus organi zat ion.v" It is thought that onee the thrombus dev elop s, it serves as a matri x for the ingrowth of papill ary structures." Ultrastruetura lly, these papillary struetures appear to closely resembl e granulation tissue, whieh further suggests a rep arativ e origin." In further support of this view is the faet that the end oth el ium -lining eelis seem to originate in histiocytes." Th e ex uberant endotheiial proliferation invol ves an autoerine loop of endotheiial secretion ofbasie fibrobl ast grow th factor. " Repo rts of oeeasional cases that did not involve thrombosis in addition to reports of the presene e of a Iymphatie eounterpart have led some authors to support Masson ' s origin al theary that IPEH is a beni gn tumor marked by prim ary endotheiia l proli feration and secondary thrombus for rnation ." Differential diagnosis. We emphas ize the imp ort anee of the differenti al diagnosis, parti eularly with respeet to oth er eondition s that have a predileetion for the he ad and neek . Most signifiea ntly, IPEH ean be mista ken for an angiosarcorna.v -" Other different ial diagn oses include mucocele," pyogenic gra nuloma," Kaposi ' s sarcoma,? and oth er vas eular eonditions such as hem angioma, angioen do thelioma, papular angioplasia, Kimura' s dis-812 ease, baeill ary ang ioma tosis, and intravenous atypi eal vase ular prol iferation."
Mieroseopieally, ang iosa reo ma usually exhib its an invasive grow th pattern, eellular pleomorphism , frequent mit oses, and neerot ic foei that are not seen in IPEH. 54 Although end otheii al eeli s are also a prominent feature in pyogenie granuloma, no surrounding vaseul ar wall is ev ident. Histologieally, Kapo si' s sareoma has no papillary frond s; rather, it displays anas tomasi ng slit-like vesse is assoc iated with a faseieul ar pattern of spindle-s haped eelis, a pla sma eeli infiltrate, and hemosid erin pigment deposition. Detecti on of Bart onella orga nisms in histologie speei mens distingui she s baeillary angiomatosis from IPEH. 55 The imp ortanee of this rep ort is that it stresses IPEH ' s likeness to, and therefo re the diffi eulty in differ enti atin g it from , similar ben ign and malign ant eonditions clinieall y, radiologieally , and histologieally. Conser vativ e surgica l exe ision is the treatment of cho ice. Inv ari ably , the pro gnosis appears to be excellent, exeept for patients with intr aeran iallesion s, whi eh ean be fatal. 56 Reeurrenee is extre mely rare and is thou ght to oeeur onl y when the underlying vaseul ar lesion is not exeised completely." 
MedNet
